Correlation between macular vessel density and number of intravitreal anti-VEGF agents for macular edema associated with branch retinal vein occlusion
Authors:
Open Access
- 8 November 2019
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 9 (1) , 1-10
Abstract
We evaluated whether the reduction of macular vessel density was correlated with the number of intravitreal injections of anti-vascular endothelial growth factor (VEGF) agents in eyes with a branch retinal vein occlusion (BRVO). The mean vessel density was determined by optical coherence tomography angiography in 29 eyes with macular edema associated with a BRVO. Our results showed that the mean vessel density in the group that had a resolution of the macular edema after one anti-VEGF injection was significantly higher than group that had a recurrence of the macular edema (P = 0.028). Single regression analysis showed that the number of intravitreal injections was significantly correlated with the reduction of the modified vessel density (r = −0.421, P = 0.023) and systemic hypertension (r = 0.377, P = 0.044). Multiple stepwise regression analysis showed that the reduction of the modified vessel density (β = −0.442, P = 0.009) and hypertension (β = 0.403, P = 0.016) were independent factors associated with the number of intravitreal injections. We conclude that the vessel density reduction can be used to predict whether recurrences of the macular edema will develop after the initial anti-VEGF injection in eyes with macular edema associated with a BRVO.Keywords
This publication has 34 references indexed in Scilit:
- Efficacy and Safety of Intravitreal Therapy in Macular Edema Due to Branch and Central Retinal Vein Occlusion: a Systematic ReviewPLOS ONE, 2013
- Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusionClinical Ophthalmology, 2012
- Grid laser photocoagulation for macular oedema due to branch retinal vein occlusion in the age of bevacizumab? Results of a prospective study with crossover designBritish Journal of Ophthalmology, 2012
- Incidence and Characteristics of Patients with Visual Impairment due to Macular Edema Secondary to Retinal Vein Occlusion in a Representative Canadian CohortJournal of Ophthalmology, 2012
- Ranibizumab for Macular Edema Due to Retinal Vein OcclusionsOphthalmology, 2012
- Ranibizumab for Macular Edema following Branch Retinal Vein OcclusionOphthalmology, 2010
- Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic ReviewOphthalmology, 2010
- INTRAVITREAL INJECTION OF BEVACIZUMAB FOR MACULAR EDEMA SECONDARY TO BRANCH RETINAL VEIN OCCLUSIONRetina, 2009
- A Randomized Trial Comparing the Efficacy and Safety of Intravitreal Triamcinolone With Standard Care to Treat Vision Loss Associated With Macular Edema Secondary to Branch Retinal Vein OcclusionArchives of Ophthalmology (1950), 2009
- Ischemic Macular Edema Recognition and Favorable Natural History in Branch Vein OcclusionArchives of Ophthalmology (1950), 1992